• If you are trying to work out whether ICON is priced attractively today, the recent share performance and its current valuation signals give you plenty to think about.
• The stock last closed at US$146.00, with a return that fell 2.6% over the past week, rose 28.6% over the past month, edged up 1.7% over the past year, but declined 22.6% year to date, 35.8% over three years and 31.7% over five years.
• These mixed returns sit against a backdrop of ongoing interest in ICON as an established player in its sector. Investors are paying attention to portfolio updates, capital allocation decisions and broader sector sentiment shifts. Together, these factors help explain why the stock has seen periods of renewed interest as well as stretches of weaker performance over multi year periods.
• ICON currently has a valuation score of 3 out of 6, reflecting that it screens as undervalued on half of the checks used here. The sections that follow will compare what different valuation approaches say about the stock, before finishing with a way to think about value that goes beyond any single model.

Approach 1: ICON Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model looks at ICON by estimating the cash the company could generate in the future, then discounting those projected cash flows back into today’s dollars. The idea is simple: if you know how much cash ICON might produce and what that is worth today, you can estimate an intrinsic value per share.

ICON’s latest reported Free Cash Flow stands at about $873.5 million. Analysts have provided forecasts out to 2030, with Simply Wall St extending those estimates using a 2 Stage Free Cash Flow to Equity model. Under this approach, projected Free Cash Flow in 2030 is $1,148.65 million, with intermediate years such as 2026 to 2029 ranging between roughly $846.66 million and $1,052.15 million before they are discounted back to today.

When all those projected cash flows are added and discounted, the model arrives at an estimated intrinsic value of $235.74 per share. Against ICON’s recent share price of $146.00, this implies the stock screens as 38.1% undervalued on this particular method.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests ICON is undervalued by 38.1%. Track this in your watchlist or portfolio, or discover 45 more high quality undervalued stocks.

Approach 2: ICON Price vs Earnings

For a profitable company like ICON, the P/E ratio is a useful way to link what you pay for the stock to the earnings the business generates today. Investors usually accept a higher P/E when they expect stronger growth or see the earnings as relatively resilient, and a lower P/E when they see higher risk or more uncertain prospects.

ICON currently trades on a P/E of 48.7x. That sits above the Life Sciences industry average P/E of 34.3x, yet below the peer group average of 73.3x. This suggests the stock is valued somewhere between broader industry levels and closer peers.

Simply Wall St also calculates a proprietary “Fair Ratio” for ICON of 25.6x. This is an estimate of what a reasonable P/E might be given factors such as the company’s earnings growth profile, industry, profit margins, market cap and specific risks. Because it brings those elements together in one number, the Fair Ratio can be more tailored than a simple comparison with peers or the industry average alone. Comparing ICON’s current P/E of 48.7x with the Fair Ratio of 25.6x, the stock currently screens as trading above that Fair Ratio.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your ICON Narrative

Earlier it was mentioned that there is an even better way to think about ICON than any single ratio or DCF. That approach is to use Narratives, where you pair a clear story about the company with your own numbers for future revenue, earnings, margins and a fair value. You can then compare that fair value to today’s price to decide whether the stock looks attractive, fully priced or expensive on your terms.

On Simply Wall St’s Community page, Narratives are presented as easy to use templates that link a written view of ICON’s business, such as the analyst consensus fair value of US$153.25 or a more cautious view closer to US$125.00, to the underlying forecasts and valuation drivers you have chosen.

Because Narratives on the platform are refreshed when new information such as ICON’s earnings, guidance, news or analyst targets is added, you can quickly see how your fair value moves relative to the live share price. You can also see how that compares with other investors who might, for example, lean toward a higher scenario around US$180.00 or a lower one around US$125.00 for the same stock.

For ICON, however, we will make it really easy for you with previews of two leading ICON narratives:

Fair value used in this bullish narrative: US$153.25

Implied discount to that fair value at the last close of US$146.00: about 4.7% undervalued

Assumed annual revenue growth used in this narrative: 124%

• Analysts in this narrative focus on bookings strength, partnerships with midsized pharma and efficiency gains from AI tools as key drivers for ICON.
• They factor in rising profit margins and share repurchases, while still highlighting clinical trial cancellations and pricing pressure as risks to the story.
• The resulting fair value of US$153.25 reflects those earnings and margin assumptions, with the stock described as close to fairly priced against that target.

Fair value used in this bearish narrative: US$125.00

Implied premium to that fair value at the last close of US$146.00: about 16.8% overvalued

Assumed annual revenue growth used in this narrative: 85%

• This more cautious ICON narrative leans on flat revenue expectations and pressure on margins from competition, client cost cutting and regulatory costs.
• It argues that elevated cancellation rates, trial volatility and geopolitical risks could cap ICON's ability to grow earnings in line with the market.
• Using those assumptions, the narrative anchors on a fair value of US$125.00, which sits at the lower end of the analyst target range.

If you want to see how these bullish and bearish narratives are fully built out in numbers and assumptions, you can move straight from these previews into the detailed community views for ICON using the narrative links above.

Do you think there's more to the story for ICON? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.